Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-10
2011-05-10
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S362000, C514S364000, C514S367000, C514S375000, C514S379000, C514S393000, C514S405000, C514S412000, C514S443000, C514S464000, C548S126000, C548S127000, C548S131000, C548S152000, C548S207000, C548S217000, C548S241000, C548S257000, C548S302700, C548S452000, C549S032000, C549S462000
Reexamination Certificate
active
07939528
ABSTRACT:
The present invention relates to novel compounds which are antagonist or inverse agonists at an opioid receptor. Such compounds are useful in the treatment of obesity and related diseases and/or conditions in mammals, particularly humans. Methods of making and using such compounds are also disclosed.
REFERENCES:
patent: 2002/0055651 (2002-05-01), Moran et al.
patent: 2004/0122237 (2004-06-01), Amiri et al.
patent: 2004/0180896 (2004-09-01), Munson et al.
patent: 2004/0192653 (2004-09-01), Munson et al.
patent: 0 684 235 (1995-11-01), None
patent: 1 167 366 (2002-01-01), None
patent: 1 486 503 (2004-12-01), None
patent: 1111037 (1968-04-01), None
patent: WO 97/37990 (1997-10-01), None
patent: WO 98/55479 (1998-12-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 99/26614 (1999-06-01), None
patent: WO 01/57020 (2001-08-01), None
patent: WO 02/18333 (2002-03-01), None
patent: WO 02/100833 (2002-12-01), None
patent: WO 03/082272 (2003-10-01), None
patent: WO 2004/026305 (2004-04-01), None
patent: WO 2004/080996 (2004-09-01), None
patent: WO 2005/032548 (2005-04-01), None
patent: 2005/066164 (2005-07-01), None
patent: WO 2005/066164 (2005-07-01), None
Chen, et al.,Multivariate Analysis and Quantitative Structure-Activity Relationships. Inhibition of Dihydrofolate Reductase and Thymidylate Synthetase by Quinazolines, J. Med. Chem., vol. 22, No. 5 (1979).
Barvian Kevin Karl
Cowan David John
Larkin Andrew Lamont
Speake Jason Daniel
Szewczyk Jerzy Ryszard
Deppenbrock Bonnie
GlaxoSmithKline LLC
Saeed Kamal A
LandOfFree
Heterocycle compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycle compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycle compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2638950